2.34 Red Light, Pola for DLBCL, Hem/Onc Question of the Week, & TAILORx with Dr. Ali Khaki
Plenary Session
English - January 24, 2020 21:51 - 1 hour - 93.1 MB - ★★★★★ - 732 ratingsScience Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
We have a variety of topics for you this week! We tackle red light therapy, polatuzumab olatuzumab vedotin in relapsed or refractory diffuse large b-cell lymphoma; we have a hematology/oncology question of the week from Dr. Emerson Chen of OHSU; and we sit down with Dr. Ali Khaki of the Fred Hutchinson Cancer Research Center to discuss his recent paper critiquing TAILORx.
Pola for DLBCL: doi.org/10.1200/JCO.19.00172
Financial COI on Twitter: doi.org/10.1001/jamainternmed.2016.8467
Ignoring Valuable Data: doi.org/10.6004/jnccn.2019.7363
Back us on Patreon! www.patreon.com/plenarysession